Xylem (XYL) Stock Chart & Stock Price History → Fidelity, Bezos, Goldman Bet Big on Tiny Biotech (From Behind the Markets) (Ad) Free XYL Stock Alerts $141.20 +1.17 (+0.84%) (As of 05/8/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Xylem Stock Price Performance5 Day Performance+2.91%1 Month Performance+10.53%3 Month Performance+15.38%6 Month Performance+45.81%Year-To-Date Performance+23.47%1 Year Performance+31.54% Receive XYL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Xylem and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceThe new financial threat that could wipe out millions…During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video XYL Stock Chart for Wednesday, May, 8, 2024 XYL Chart by TradingView Xylem Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/08/2024$140.03$141.20+0.84%$141.30$139.75891,570 shs$34.23 billion05/07/2024$139.21$140.03+0.59%$141.25$138.671.27 million shs$33.95 billion05/06/2024$137.21$139.21+1.46%$139.21$137.48953,468 shs$33.75 billion05/03/2024$135.99$137.21+0.90%$138.46$135.161.40 million shs$33.26 billion05/02/2024$130.96$135.99+3.84%$137.18$132.022.78 million shs$32.96 billion05/01/2024$130.70$130.96+0.20%$133.07$130.171.77 million shs$31.74 billion Get the Latest News and Ratings for XYL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Xylem and its competitors with MarketBeat's FREE daily newsletter. 04/30/2024$132.60$130.70-1.43%$133.71$130.581.40 million shs$31.68 billion04/29/2024$132.40$132.60+0.15%$133.34$131.671.28 million shs$32.14 billion04/26/2024$130.61$132.40+1.37%$132.65$129.791.11 million shs$32.09 billion04/25/2024$130.67$130.61-0.05%$131.20$128.10963,557 shs$31.66 billion04/24/2024$130.67$130.67$132.23$129.581.05 million shs$31.67 billion04/23/2024$128.98$130.67+1.31%$130.86$129.28945,635 shs$31.67 billion04/22/2024$127.84$128.98+0.89%$129.79$127.451.06 million shs$31.26 billion04/19/2024$127.16$127.84+0.53%$128.66$126.962.07 million shs$30.99 billion04/18/2024$126.22$127.16+0.74%$128.46$126.911.13 million shs$30.82 billion04/17/2024$128.02$126.22-1.41%$128.49$124.661.44 million shs$30.60 billion04/16/2024$127.29$128.02+0.57%$128.73$126.111.15 million shs$31.03 billion04/15/2024$128.11$127.29-0.64%$129.88$126.70968,617 shs$30.86 billion04/12/2024$128.81$128.11-0.54%$128.67$127.19885,681 shs$31.05 billion04/11/2024$128.19$128.81+0.48%$129.10$127.19941,660 shs$31.22 billion04/10/2024$128.93$128.19-0.57%$128.78$126.02996,438 shs$31.07 billion04/09/2024$127.75$128.93+0.92%$128.99$126.48782,131 shs$31.25 billion04/08/2024$128.27$127.75-0.41%$129.07$127.62739,077 shs$30.97 billion04/05/2024$127.25$128.31+0.83%$128.94$127.00753,604 shs$31.10 billion04/04/2024$128.92$127.25-1.30%$130.01$127.031.13 million shs$30.77 billion04/03/2024$128.11$128.92+0.63%$129.73$127.621.15 million shs$31.17 billion04/02/2024$128.64$128.11-0.41%$128.70$127.171.14 million shs$30.97 billion04/01/2024$129.24$128.64-0.46%$129.51$127.91695,992 shs$31.10 billion03/29/2024$129.22$129.24+0.02%$130.22$129.15953,174 shs$31.25 billion03/28/2024$129.38$129.22-0.12%$130.22$129.15953,160 shs$31.24 billion03/27/2024$127.90$129.38+1.16%$129.45$128.10956,252 shs$31.28 billion03/26/2024$127.76$127.90+0.11%$128.49$127.26853,053 shs$30.92 billion03/25/2024$129.21$127.76-1.12%$129.36$127.50888,076 shs$30.89 billion03/22/2024$129.99$129.14-0.65%$130.48$128.82732,393 shs$31.22 billion03/21/2024$128.69$129.99+1.01%$130.86$129.201.03 million shs$31.43 billion03/20/2024$128.45$128.69+0.19%$128.69$127.23987,831 shs$31.11 billion03/19/2024$127.50$128.45+0.75%$128.53$127.37806,732 shs$31.06 billion03/18/2024$127.27$127.50+0.18%$127.96$126.82720,019 shs$30.83 billion03/15/2024$127.96$127.27-0.54%$128.24$126.181.54 million shs$30.77 billion03/14/2024$128.02$127.96-0.05%$128.10$126.631.34 million shs$30.94 billionFidelity, Bezos, Goldman Bet Big on Tiny Biotech (Ad)Are you ready for a major shift in the investment world? There's a new drug The Wall Street Journal is calling the "King Kong" of drugs.Don't miss out on the "next Ozempic" >>>03/13/2024$128.46$128.02-0.34%$128.53$127.48872,495 shs$30.95 billion03/12/2024$126.18$128.46+1.81%$128.51$126.42999,059 shs$31.06 billion03/11/2024$127.08$126.18-0.71%$127.04$125.511.02 million shs$30.51 billion03/08/2024$126.97$127.08+0.09%$127.98$126.58744,164 shs$30.72 billion03/07/2024$126.35$126.97+0.49%$127.70$126.51905,451 shs$30.70 billion03/06/2024$126.19$126.35+0.13%$127.18$125.741.12 million shs$30.55 billion03/05/2024$127.86$126.19-1.31%$127.86$125.68818,344 shs$30.51 billion03/04/2024$127.94$127.86-0.06%$128.58$127.60917,274 shs$30.91 billion03/01/2024$127.05$127.94+0.70%$128.16$126.22813,155 shs$30.84 billion02/29/2024$125.63$127.05+1.13%$127.48$125.251.83 million shs$30.63 billion02/28/2024$125.69$125.63-0.05%$126.31$125.26876,911 shs$30.29 billion02/27/2024$125.71$125.69-0.02%$126.42$124.74932,171 shs$30.30 billion02/26/2024$125.63$125.71+0.06%$127.03$125.211.12 million shs$30.31 billion02/23/2024$125.10$125.63+0.42%$126.54$125.37736,655 shs$30.29 billion02/22/2024$123.46$125.10+1.33%$125.33$123.73897,354 shs$30.16 billion02/21/2024$124.10$123.46-0.52%$124.46$122.701.04 million shs$29.76 billion02/20/2024$123.79$124.10+0.25%$124.68$122.221.41 million shs$29.92 billion02/19/2024$123.79$123.79$124.75$123.501.21 million shs$29.84 billion02/16/2024$124.41$123.77-0.51%$124.75$123.501.21 million shs$29.84 billion02/15/2024$124.16$124.41+0.20%$124.98$123.74893,488 shs$29.99 billion02/14/2024$121.73$124.16+2.00%$124.21$122.071.00 million shs$29.93 billion02/13/2024$123.30$121.73-1.27%$122.54$120.791.34 million shs$29.35 billion02/12/2024$124.30$123.30-0.80%$124.49$123.061.26 million shs$29.73 billion02/09/2024$122.38$124.30+1.57%$124.40$122.061.58 million shs$29.97 billion02/08/2024$123.35$122.38-0.79%$123.71$121.141.90 million shs$29.50 billion02/07/2024$119.58$123.35+3.15%$124.56$120.403.50 million shs$29.74 billion Related Companies: IDEX Stock Price Chart Graco Stock Price Chart Rockwell Automation Stock Price Chart Ingersoll Rand Stock Price Chart Dover Stock Price Chart Axon Enterprise Stock Price Chart Ball Stock Price Chart Ferguson Stock Price Chart Hubbell Stock Price Chart Tenaris Stock Price Chart Receive XYL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Xylem and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:XYL) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsWatch this FREE trading tutorial while it’s still availableInvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Xylem Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.